GIM
AGIO icon

Granahan Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Granahan Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41,886
Closed -$1.39M – 147
2025
Q2 		$1.39M Sell
41,886
-90,222
-68% -$2.73M 0.06% 142
2025
Q1 		$3.87M Buy
132,108
+16,421
+14% +$545K 0.19% 110
2024
Q4 		$3.8M Sell
115,687
-35,098
-23% -$1.65M 0.16% 124
2024
Q3 		$6.7M Buy
150,785
+13,947
+10% +$633K 0.26% 108
2024
Q2 		$5.9M Buy
+136,838
New +$4.94M 0.24% 116

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Granahan Investment Management's AGIO Position: Q3 2025 in Review

Granahan Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 41,886 shares — an estimated $1.39M sold.

Granahan Investment Management first reported a position in AGIO in Q2 2024 and held it in 5 quarters. The position peaked at $6.7M in Q3 2024. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Granahan Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Granahan Investment Management sold 41,886 Agios Pharmaceuticals shares in Q3 2025, an estimated $1.39M.
  • Granahan Investment Management first reported a position in Agios Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Granahan Investment Management's Agios Pharmaceuticals position peaked at $6.7M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Granahan Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.